IGAN - IGA NEPHROPATHY
Clinical trials for IGAN - IGA NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IGAN - IGA NEPHROPATHY trials appear
Sign up with your email to follow new studies for IGAN - IGA NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive global study reveals hidden toll of kidney disease in dialysis patients
Knowledge-focused CompletedThis study looked at medical records from about 70,000 adults on hemodialysis worldwide to find out how many have IgA nephropathy (a type of kidney disease) and how it affects their health. Researchers compared patients with IgA nephropathy to other dialysis patients to measure t…
Matched conditions: IGAN - IGA NEPHROPATHY
Sponsor: Arbor Research Collaborative for Health • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC
-
First human test of kidney disease drug shows promise
Knowledge-focused CompletedThis early-stage study tested a new drug called VIS649 in 51 healthy adults to see if it is safe and how the body processes it. The drug aims to treat IgA nephropathy, a kidney disease. Participants received either the drug or a placebo, and researchers monitored side effects and…
Matched conditions: IGAN - IGA NEPHROPATHY
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:48 UTC